🔥 We are very excited to announce our partnership with InSCREENeX GmbH. 🤝 By joining forces and combining InSCREENeX’ cutting-edge CI-SCREEN methodology with AlveoliX’ patented organ-on-chip technology, we co-developed a new immortalized alveolar cell line, specially tuned for on-chip applications. 🧫 AXiAECs derived from primary alveolar epithelial cells and grown on-chip feature key aspects of the distal…
More🏅 AlveoliX has been shortlisted for the Swiss Medtech Award 2022! 🌟 We will be pitching our company to the Jury on April 6th. Looking forward to the hearing! 🙏🏻 Thank you Swiss Medtech for choosing AlveoliX as one of the 6 companies invited to participate in the vibrant Swiss Medtech Award 2022. 🔗 More info about the shortlisted…
More🏆 AlveoliX is part of the Top 5 Startup out of 594 building Lab-on-a-Chip Solutions! 🔸 Interested in discovering other emerging technologies? Check out the article. 🙏🏼 Thank you StartUs Insights for featuring us.
More🎂 Happy Birthday to AlveoliX!🥂 We are thrilled and thankful to celebrate our 3rd anniversary.🤗 Thank you to all those who have trusted and supported us. We keep working to improve our range of applications and increase accessibility to our technology. Because we are stronger together.
MoreAre you interested in using microphysiological systems in your research? Check out the new NA3RsC MPS Hub, a new, user-friendly resource for you that highlights MPS providers with commercially available technologies. In this hub, you can quickly sort by organ-type(s) offered, access top 3 publications, links to company websites, and find contact information. And you’ll know that all members are supporters…
MoreLast week we had the pleasure to host our partners from Roche Basel in the first Biochip Storming AX event. Throughout the different sessions, we addressed the challenges and opportunities of the organ-on-chip technology within the drug development pipeline. Thanks to Lauriane CABON and all the participants for making it such as successful day, full of exciting…
MoreWe are proud to be part of The North American 3Rs Collaborative’s (NA3RsC) Micro Physiological Systems (MPS) initiative. The MPS initiative works together to increase industry adoption and regulatory acceptance of MPS technologies with the ultimate goal of refining, reducing, and replacing research animals. Learn more about our efforts in this group on the NA3RsC…
MoreCongratulations to Lea de Maddalena for winning the Best Poster Award at EUROoCS2021 Conference! Thank you to the organizing team Maria Tenje from Uppsala University for this excellent panel of speakers and very interesting talks. It was a pleasure to connect with the participants and we are looking forward to next year’s conference.
MoreWe are thrilled to be part of the new BRIDGE Discovery project granted by the SNSF Swiss National Science Foundation and Innosuisse to the Laboratory of Microbiology at the Université de Neuchâtel (LAMUN) in cooperation with the CHUV / Centre hospitalier universitaire vaudois, the SIB Swiss Institute of Bioinformatics, and SiMPLInext SA. The project led by Prof. Pilar Junier aims at establishing a novel solution to the burden imposed by raising antibiotic resistance by applying the innovative concept of “environmental interference” to human…
More